Blood-Borne Diseases

The investigational therapy’s data points to a path towards a potential functional cure.

A shorter dosing period and no extra risk of suffering acute myocardial infarction means the newer 2-dose hepatitis B vaccine is an attractive option for protection.

The cases are in the pediatric population and come from 11 countries in the WHO European Region and 1 country in the WHO Region of the Americas.

First-in-class triaminopyrimidine demonstrates antimalarial efficacy in first-in-human test of dosing, kinetics, and clearing parasite in infected volunteers.

“People don’t recognize that at least 1 in 5 of the deaths from opioids may result from endocarditis,” said National Institute of Drug Abuse (NIDA) director Dr. Nora Volkow, adding that endocarditis is “100% preventable.”

Johnson & Johnson’s vaccine regimen induced neutralizing antibody responses in 98% of participants 21 days after the second dose.

The National Institutes of Health (NIH) announces single injection of monoclonal antibody against the Plasmodium mosquito-borne parasite prevented malaria throughout 9 month phase 1 trial.

The first case reported in Guinea has resulted in a patient's death, while health authorities work to reduce outbreak risks.

EVD outbreaks this year serve as a reminder of the virus’ severity and the importance of having a containment strategy in place.

The recombinant human IgG1κ monoclonal antibody binds and neutralizes the virus.

An outbreak which began at an infected healthcare worker's funeral has resulted in nearly 100 contact follow-ups.

Series completion rates were different among patient groups, the study authors observed.

This technology is effective in cases that are difficult to diagnose.

An assessment of a comparative study between leading options for a burdensome infection.

More than 13 million children did not receive their first DTP vaccine dose in 2019—and investigators anticipate the 2020 rate will be worse.

John Johnson, lead for Ebola vaccination with MSF France, describes the "ring strategy" used in controlling several infectious disease threats.

The latest Ebola outbreak in western Democratic Republic of Congo has led to at least 100 cases as of Friday, according to WHO.

Infectious disease specialists explain how long term international cooperation with impacted societies can help to stop the cycle of Ebola outbreaks.

How might this new outbreak in Mbandaka differ from the recent outbreak in Kivu, a more conflict-prone region of the DRC?

West and Central African nations have been developing infrastructure to combat ebola, malaria, malnutrition, and more.

In Mbandaka, an 11th outbreak of Ebola is emerging. This outbreak has renewed questions about what makes the virus such a challenge for Congolese society to reign in.

A modeling study from Imperial College shows the pandemic may have significant effect on mortality among other infectious disease patients.

The European Commission has granted Marketing Authorization for a 2-dose Ebola vaccine regimen.

A review of the latest infectious disease news.

As of June 1, there have been at least 6 cases of Ebola detected in Mbandaka, a port city with a population of more than 1.2 million people.

Investigators detailed a promising new approach to fighting malaria with an antibody that targets a specific malaria protein, triggering the pathogen to self-destruct.

A new case of Ebola has been confirmed in the city of Beni in the Democratic Republic of the Congo.

How has treating infections changed with the availability of experimental vaccines and therapeutics, and how can we apply this to COVID-19 today?